| 58160-842-52 |
58160-842 |
VACCINE |
BOOSTRIX |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
SUSPENSION |
INTRAMUSCULAR |
20090724 |
N/A |
BLA |
BLA125106 |
GlaxoSmithKline Biologicals SA |
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) |
8 ug/.5mL; 2.5 ug/.5mL; 8 ug/.5mL; 5 [iU]/.5mL; 2.5 [iU]/.5mL |
10 SYRINGE in 1 CARTON (58160-842-52) / .5 mL in 1 SYRINGE (58160-842-43) |
| 58160-842-11 |
58160-842 |
VACCINE |
BOOSTRIX |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
SUSPENSION |
INTRAMUSCULAR |
20090724 |
N/A |
BLA |
BLA125106 |
GlaxoSmithKline Biologicals SA |
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) |
8 ug/.5mL; 2.5 ug/.5mL; 8 ug/.5mL; 5 [iU]/.5mL; 2.5 [iU]/.5mL |
10 VIAL in 1 CARTON (58160-842-11) / .5 mL in 1 VIAL (58160-842-01) |
| 50090-1377-1 |
50090-1377 |
VACCINE |
BOOSTRIX |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
SUSPENSION |
INTRAMUSCULAR |
20090724 |
N/A |
BLA |
BLA125106 |
A-S Medication Solutions |
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) |
8 ug/.5mL; 2.5 ug/.5mL; 8 ug/.5mL; 5 [iU]/.5mL; 2.5 [iU]/.5mL |
1 SYRINGE in 1 POUCH (50090-1377-1) / .5 mL in 1 SYRINGE |
| 50090-1377-0 |
50090-1377 |
VACCINE |
BOOSTRIX |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
SUSPENSION |
INTRAMUSCULAR |
20090724 |
N/A |
BLA |
BLA125106 |
A-S Medication Solutions |
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) |
8 ug/.5mL; 2.5 ug/.5mL; 8 ug/.5mL; 5 [iU]/.5mL; 2.5 [iU]/.5mL |
10 SYRINGE in 1 CARTON (50090-1377-0) / .5 mL in 1 SYRINGE (50090-1377-2) |
| 50090-1831-0 |
50090-1831 |
VACCINE |
BOOSTRIX |
Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed |
SUSPENSION |
INTRAMUSCULAR |
20090724 |
N/A |
BLA |
BLA125106 |
A-S Medication Solutions |
BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED); BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED); CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) |
8 ug/.5mL; 2.5 ug/.5mL; 8 ug/.5mL; 5 [iU]/.5mL; 2.5 [iU]/.5mL |
10 VIAL in 1 POUCH (50090-1831-0) / .5 mL in 1 VIAL (50090-1831-9) |